In this study, for the first time, we uncovered the mechanisms by which SNHG4 facilitates the survival of PCa cells and resistance to enzalutamide, and we investigated a positive feedback loop that may enhance the overexpression of SNHG4 in prostate cancer. Here, SNHG4 is linked to prostate carcinoma.